1380650-53-2 (BMS-986020 sodium | LPL Receptor,sodium 1-{4'-3-methyl-4-({(1R)-1-phenylethoxycarbonyl}amino)-1,2-oxazol-5-yl-1,1'-biphenyl-4-yl}cyclopropane-1-carboxylate)

BMS 986020 sodium salt;Sodium 1-(4-{4-[3-methyl-4-({[(1R)-1-phenylethoxy]carbonyl}amino)-1,2-oxazol-5-yl]phenyl}phenyl)cyclopropane-1-carboxylate;sodium (R)-1-(4'-(3-methyl-4-(((1-phenylethoxy)carbonyl)amino)isoxazol-5-yl)-[1,1'-biphenyl]-4-yl)cyclopropane-1-carboxylate;BMS-986020 (sodium);BMS-986020 sodium;sodium 1-{4'-3-methyl-4-({(1R)-1-phenylethoxycarbonyl}amino)-1,2-oxazol-5-yl-1,1'-biphenyl-4-yl}cyclopropane-1-carboxylate;AM152 (sodium);Sodium1-(4-{4-[3-methyl-4-({[(1R)-1-phenylethoxy]carbonyl}amino)-1,2-oxazol-5-yl]phenyl}phenyl)cyclopropane-1-carboxylate;sodium;1-[4-[4-[3-methyl-4-[[(1R)-1-phenylethoxy]carbonylamino]-1,2-oxazol-5-yl]phenyl]phenyl]cyclopropane-1-carboxylate;DA-71594;G16055;1380650-53-2;HY-100619A;CS-0102715;

MFCD30749917

QDCOVTLBRMPIMY-FSRHSHDFSA-M

1S/C29H26N2O5.Na/c1-18-25(30-28(34)35-19(2)20-6-4-3-5-7-20)26(36-31-18)23-10-8-21(9-11-23)22-12-14-24(15-13-22)29(16-17-29)27(32)33;/h3-15,19H,16-17H2,1-2H3,(H,30,34)(H,32,33);/q;+1/p-1/t19-;/m1./s1

[Na+].[O-]C(C1(C2C=CC(C3C=CC(C4=C(C(C)=NO4)NC(=O)O[C@H](C)C4C=CC=CC=4)=CC=3)=CC=2)CC1)=O